Ares Commercial Real Estate Corporation — Q1 2024 Form 10-Q Summary
Business Context and Reporting Period
Ares Commercial Real Estate Corporation is an externally managed REIT and specialty finance company focused primarily on originating and investing in commercial real estate loans and related investments. The filing covers the three months ended March 31, 2024, compared with the three months ended March 31, 2023, and the balance sheet as of March 31, 2024 compared with December 31, 2023.
Key Financial Metrics
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Total revenue | $18.7 million | $26.5 million |
| Interest income | $44.0 million | $49.5 million |
| Interest expense | $28.8 million | $23.0 million |
| Net interest margin | $15.2 million | $26.5 million |
| Total expenses | $8.6 million | $6.2 million |
| Provision for current expected credit losses | $(22.3) million | $21.0 million |
| Realized losses on loans | $45.7 million | $5.6 million |
| Net loss attributable to common stockholders | $(12.3) million | $(6.4) million |
| Loss per share | $(0.23) | $(0.12) |
| Dividend declared per share | $0.25 | $0.35 |
Total assets declined to $2.11 billion from $2.28 billion at year-end 2023. Stockholders’ equity declined to $601.1 million from $625.8 million, primarily reflecting the quarterly net loss and dividend declaration. Loans held for investment totaled $2.01 billion before the CECL reserve and $1.87 billion net of the reserve. The CECL reserve for funded loans was $139.8 million, with an additional $1.1 million reserve for unfunded commitments.
Cash and cash equivalents were $99.5 million at March 31, 2024, compared with $110.5 million at December 31, 2023. Cash provided by operating activities was $11.4 million. Investing activities provided $134.0 million, primarily from loan repayments and the sale of a loan, while financing activities used $156.3 million, including $128.2 million of consolidated VIE debt repayments and $18.2 million of dividends paid. Management reported approximately $136 million of liquidity as of May 7, 2024, consisting of $86 million of unrestricted cash and $50 million of available secured funding capacity.
Total financing-agreement debt was $885.3 million at March 31, 2024, excluding $595.1 million of consolidated CLO securitization debt. Total financing commitments were $1.535 billion, leaving approximately $649.7 million of stated capacity under those agreements. The company stated that it was in compliance with its financial covenants at March 31, 2024.
Material Changes Versus the Prior Comparable Period
- Net interest margin decreased 43% to $15.2 million, as lower average earning assets, higher funding costs, increased non-accrual loans and the expiration of interest-rate hedges more than offset the benefit of higher SOFR.
- Total revenue decreased 29%, despite $3.5 million of rental revenue from real estate owned, because interest income declined and the prior-year period had no real-estate-owned expenses.
- The company recorded $45.7 million of realized loan losses, including $43.1 million on a discounted payoff of an Illinois office loan and $1.7 million on a Washington multifamily loan. A $995 thousand unrealized loss on a loan held for sale was also realized upon its January 2024 sale.
- The CECL reserve declined from $159.9 million at December 31, 2023 to $139.8 million at March 31, 2024, mainly because of realized losses on two risk-rated 5 loans, loan repayments and shorter remaining loan terms. This produced a $22.3 million CECL benefit in the quarter, although reserves increased for certain risk-rated 4 and 5 loans.
- Non-accrual loans decreased from nine loans with a $399.3 million carrying value at year-end 2023 to seven loans with a $266.5 million carrying value at March 31, 2024.
- The loan portfolio declined to 44 loans with $2.04 billion of outstanding principal. The company funded approximately $13.0 million and received approximately $78.4 million of principal repayments during the quarter.
- The quarterly dividend was reduced to $0.25 per share from $0.35 per share in the prior-year quarter. A $0.25 per share dividend was also declared for Q2 2024.
Guidance, Outlook, Risks and Unusual Items
The filing does not provide formal earnings or portfolio guidance. Management expects primary liquidity sources to be sufficient for operating and financing needs for at least the next 12 months, but notes that this expectation depends on borrower collections, financing availability, covenant compliance and market conditions.
Management highlighted persistent inflation, higher-for-longer interest rates, tighter credit conditions, elevated property insurance and operating costs, geopolitical uncertainty and continued weakness in the office sector. Remote work, high vacancy, refinancing risk and lower property values may increase defaults and impair collateral recoveries.
- Seven loans were on non-accrual status at quarter-end. A California office loan was in maturity default and subject to foreclosure, while a New Jersey mezzanine loan was in default for unpaid interest.
- In May 2024, a $68.6 million North Carolina office loan was not repaid at maturity and triggered an event of default.
- On May 8, 2024, the secured term loan was amended, including changes to interest-rate step-ups and financial covenants; the company paid down $10 million, reducing the balance to $140 million.
- The company terminated its unused $180 million MetLife Facility on May 8, 2024.
- Several lending facilities and the Capital One guaranty were amended after quarter-end to clarify tangible-net-worth calculations. These amendments and the new term-loan covenants warrant review because covenant definitions can affect borrowing capacity and distributions.
- The CLO structures contain overcollateralization tests. Failure to satisfy those tests could redirect cash flows to senior note repayment and reduce cash available to the company.
- The company’s stated leverage policy currently contemplates debt-to-equity leverage of no more than 4.5-to-1, although actual future leverage may vary.
- The company had no outstanding interest-rate derivatives designated as cash-flow hedges at March 31, 2024. Its prior interest-rate swap expired in December 2023.
Most Important Facts for Investors to Verify
- Review the performance, collateral values, maturity dates and workout status of the seven non-accrual loans, particularly the California, New Jersey and North Carolina office-related exposures.
- Assess whether the $139.8 million funded CECL reserve adequately reflects office-sector valuation pressure, refinancing risk and potential additional realized losses.
- Reconcile total debt, including secured funding, notes payable, the term loan and consolidated CLO debt, with available liquidity and near-term facility maturities.
- Review the post-quarter-end covenant amendments and determine whether reduced tangible-net-worth thresholds or other changes constrain dividends, asset sales, leverage or funding capacity.
- Evaluate dividend sustainability against recurring earnings, cash collections, CECL adjustments, CLO cash-flow priority and the $0.25 per share quarterly dividend.
- Consider the difference between GAAP net loss and cash generation: Q1 operating cash flow was positive, but the quarter included substantial realized loan losses and significant debt repayments.
- Confirm the company’s continued REIT qualification, 1940 Act exemption, financing covenant compliance and ability to refinance facilities maturing beginning in 2025.